The 5-HTTLPR genotype modulates heart rate variability and its adjustment by pharmacological panic challenge in healthy men

Journal of Psychiatric Research

Volumn 50, Issue 1, 2014, Pages 51-58

  Agorastos, Agorastos ^a   Kellner, Michael ^a   Stiedl, Oliver ^b   Muhtz, Christoph ^a   Becktepe, Jos S ^a   Wiedemann, Klaus ^a   Demiralay, Cüneyt ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

5 HTTLPR (serotonin transporter linked polymorphic region); Autonomic nervous system; Cholecystokinin tetrapetide (CCK 4); Heart rate variability; Panic; Parasympathetic nervous system; Stress; Sympathetic nervous system

Indexed keywords

SEROTONIN TRANSPORTER; TETRAGASTRIN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD SAMPLING; CAUCASIAN; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; ELECTROCARDIOGRAM; FEMALE; GENOTYPE; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NORMAL HUMAN; PANIC; PARASYMPATHETIC TONE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPATHETIC TONE; VAGUS NERVE STIMULATION; VENOUS BLOOD; YOUNG ADULT;

5-HTTLPR (SEROTONIN-TRANSPORTER-LINKED POLYMORPHIC REGION); AUTONOMIC NERVOUS SYSTEM; CHOLECYSTOKININ TETRAPETIDE (CCK-4); HEART RATE VARIABILITY; PANIC; PARASYMPATHETIC NERVOUS SYSTEM; STRESS; SYMPATHETIC NERVOUS SYSTEM;

ANALYSIS OF VARIANCE; AUTONOMIC AGENTS; ELECTROCARDIOGRAPHY; GENOTYPE; HEART RATE; HUMANS; MALE; PANIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TETRAGASTRIN;

EID: 84892535578     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.11.013     Document Type: Article

References (108)

1. Agorastos A., Boel J.A., Heppner P.S., Hager T., Moeller-Bertram T., Haji U., et al. Diminished vagal activity and blunted diurnal variation of heart rate dynamics in posttraumatic stress disorder. Stress 2013, 16(3):300-310.
2. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Berger A.C., Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 1981, 213(4504):220-222.
3. Arinami T., Ohtsuki T., Yamakawa-Kobayashi K., Amemiya H., Fujiwara H., Kawata K., et al. Asynergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 1999, 81(6):853-856.
4. Audero E., Coppi E., Mlinar B., Rossetti T., Caprioli A., Banchaabouchi M.A., et al. Sporadic autonomic dysregulation and death associated with excessive serotonin autoinhibition. Science 2008, 321(5885):130-133.
5. Beaver K.M., Vaughn M.G., Wright J.P., Delisi M. An interaction between perceived stress and 5HTTLPR genotype in the prediction of stable depressive symptomatology. Am J Orthopsychiatry 2012, 82(2):260-266.
6. Benjamini Y., Hochberg J. Controlling the false discovery rate: a practical and powerful approach to multiple testing. JRoyal Stat Soc S B 1995, 57(1):289-300.
7. Benkelfat C., Bradwejn J., Meyer E., Ellenbogen M., Milot S., Gjedde A., et al. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. Am J Psychiatry 1995, 152(8):1180-1184.
8. Billman G.E. Heart rate variability - a historical perspective. Front Physiol 2011, 2:86.
9. Billman G.E. The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol 2013, 4:26.
10. Bozzini S., Gambelli P., Boiocchi C., Schirinzi S., Falcone R., Buzzi P., et al. Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms. Int J Mol Med 2009, 24(6):813-818.
11. Bradwejn J., Koszycki D., Bourin M. Dose ranging study of the effects of cholecystokinin in healthy volunteers. JPsychiatry Neurosci 1991, 16(2):91-95.
12. Brummett B.H., Siegler I.C., Ashley-Koch A., Williams R.B. Effects of 5HTTLPR on cardiovascular response to an emotional stressor. Psychosom Med 2011, 73(4):318-322.
13. Camm A.J., Malik M., Bigger J.T., Breithardt G., Cerutti S., Cohen R.J., et al. Heart rate variability - standards of measurement, physiological interpretation, and clinical use. Circulation 1996, 93(5):1043-1065.
14. Carroll D., Phillips A.C., Der G. Body mass index, abdominal adiposity, obesity, and cardiovascular reactions to psychological stress in a large community sample. Psychosom Med 2008, 70(6):653-660.
15. Carroll D., Phillips A.C., Hunt K., Der G. Symptoms of depression and cardiovascular reactions to acute psychological stress: evidence from a population study. Biol Psychol 2007, 75(1):68-74.
16. Caspi A., Hariri A.R., Holmes A., Uher R., Moffitt T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010, 167(5):509-527.
17. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301(5631):386-389.
18. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 1993, 18(1):1-32.
19. Clarke H., Flint J., Attwood A.S., Munafo M.R. Association of the 5-HTTLPR genotype and unipolar depression: a meta-analysis. Psychol Med 2010, 40(11):1767-1778.
20. Coto E., Reguero J.R., Alvarez V., Morales B., Batalla A., Gonzalez P., et al. 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clin Sci (Lond) 2003, 104(3):241-245.
21. Demiralay C., Jahn H., Kellner M., Yassouridis A., Wiedemann K. Differential effects to CCK-4-induced panic by dexamethasone and hydrocortisone. World J Biol Psychiatry 2012, 13(7):526-534.
22. Deuschle M., Schredl M., Schilling C., Wust S., Frank J., Witt S.H., et al. Association between a serotonin transporter length polymorphism and primary insomnia. Sleep 2010, 33(3):343-347.
23. Dillon D.J., Gorman J.M., Liebowitz M.R., Fyer A.J., Klein D.F. Measurement of lactate-induced panic and anxiety. Psychiatry Res 1987, 20(2):97-105.
24. Dinas P.C., Koutedakis Y., Flouris A.D. Effects of active and passive tobacco cigarette smoking on heart rate variability. Int J Cardiol 2013, 163(2):109-115.
25. Ellis A.J., Beevers C.G., Hixon J.G., McGeary J.E. Serotonin transporter promoter region (5-HTTLPR) polymorphism predicts resting respiratory sinus arrhythmia. Psychophysiology 2011, 48(7):923-926.
26. Eser D., Schule C., Baghai T., Floesser A., Krebs-Brown A., Enunwa M., et al. Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Psychopharmacology (Berl) 2007, 192(4):479-487.
27. Eser D., Uhr M., Leicht G., Asmus M., Langer A., Schule C., et al. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks. JPsychiatr Res 2011, 45(1):60-63.
28. Fritz C.O., Morris P.E., Richler J.J. Effect size estimates: current use, calculations, and interpretation. JExp Psychol Gen 2012, 141(1):2-18.
29. Fumeron F., Betoulle D., Nicaud V., Evans A., Kee F., Ruidavets J.B., et al. Serotonin transporter gene polymorphism and myocardial infarction: etude Cas-Temoins de l'Infarctus du Myocarde (ECTIM). Circulation 2002, 105(25):2943-2945.
30. Ginty A.T., Conklin S.M. High perceived stress in relation to life events is associated with blunted cardiac reactivity. Biol Psychol 2011, 86(3):383-385.
31. Ginty A.T., Gianaros P.J., Derbyshire S.W., Phillips A.C., Carroll D. Blunted cardiac stress reactivity relates to neural hypoactivation. Psychophysiology 2013, 50(3):219-229.
32. Ginty A.T., Phillips A.C., Roseboom T.J., Carroll D., Derooij S.R. Cardiovascular and cortisol reactions to acute psychological stress and cognitive ability in the Dutch famine birth cohort study. Psychophysiology 2012, 49(3):391-400.
33. Gorman J.M., Sloan R.P. Heart rate variability in depressive and anxiety disorders. Am Heart J 2000, 140(Suppl.4):77-83.
34. Gotlib I.H., Joormann J., Minor K.L., Hallmayer J. HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol Psychiatry 2008, 63(9):847-851.
35. Grabe H.J., Spitzer C., Schwahn C., Marcinek A., Frahnow A., Barnow S., et al. Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population. Am J Psychiatry 2009, 166(8):926-933.
36. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., et al. Allelic variation of human serotonin transporter gene expression. Journal of Neurochemistry 1996, 66(6):2621-2624.
37. Heinz A., Smolka M.N., Braus D.F., Wrase J., Beck A., Flor H., et al. Serotonin transporter genotype (5-HTTLPR): effects of neutral and undefined conditions on amygdala activation. Biol Psychiatry 2007, 61(8):1011-1014.
38. Heponiemi T., Elovainio M., Pulkki L., Puttonen S., Raitakari O., Keltikangas-Jarvinen L. Cardiac autonomic reactivity and recovery in predicting carotid atherosclerosis: the cardiovascular risk in young Finns study. Health Psychol 2007, 26(1):13-21.
39. Hildreth C.M., Padley J.R., Pilowsky P.M., Goodchild A.K. Impaired serotonergic regulation of heart rate may underlie reduced baroreflex sensitivity in an animal model of depression. Am J Physiol Heart Circ Physiol 2008, 294(1):H474-H480.
40. Homberg J.R., Lesch K.P. Looking on the bright side of serotonin transporter gene variation. Biol Psychiatry 2011, 69(6):513-519.
41. Iordanidou M., Tavridou A., Petridis I., Arvanitidis K.I., Christakidis D., Vargemezis V., et al. The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes. Clin Chim Acta 2010, 411(3-4):167-171.
42. Jacobs N., Kenis G., Peeters F., Derom C., Vlietinck R., van Os J. Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Arch Gen Psychiatry 2006, 63(9):989-996.
43. Jarrin D.C., McGrath J.J., Giovanniello S., Poirier P., Lambert M. Measurement fidelity of heart rate variability signal processing: the devil is in the details. Int J Psychophysiol 2012, 86(1):88-97.
44. Jerabek I., Boulenger J.P., Bradwejn J., Lavallee Y.J., Jolicoeur F.B. CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects. Eur Neuropsychopharmacol 1999, 9(1-2):149-155.
45. Johnson P.L., Lightman S.L., Lowry C.A. Afunctional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic. Ann N Y Acad Sci 2004, 1018:58-64.
46. Jordan D. Vagal control of the heart: central serotonergic (5-HT) mechanisms. Exp Physiol 2005, 90(2):175-181.
47. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011, 68(5):444-454.
48. Kauppila E., Vanninen E., Kaurijoki S., Karhunen L., Pietilainen K.H., Rissanen A., et al. Influence of serotonin transporter gene polymorphism (5-HTTLPR polymorphism) on the relation between brain 5-HT transporter binding and heart rate corrected cardiac repolarization interval. PLoS One 2013, 8(1):e50303.
49. Kellner M. Experimental panic provocation in healthy man-a translational role in anti-panic drug development?. Dialogues Clin Neurosci 2011, 13(4):485-493.
50. Kellner M., Muhtz C., Demiralay C., Husemann J., Koelsch W., Yassouridis A., et al. The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype. JPsychiatr Res 2009, 43(6):642-648.
51. Kellner M., Yassouridis A., Hua Y., Wendrich M., Jahn H., Wiedemann K. Intravenous C-type natriuretic peptide augments behavioral and endocrine effects of cholecystokinin tetrapeptide in healthy men. JPsychiatr Res 2002, 36(1):1-6.
52. Kemp A.H., Quintana D.S., Gray M.A., Felmingham K.L., Brown K., Gatt J.M. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 2010, 67(11):1067-1074.
53. Kremer I., Bachner-Melman R., Reshef A., Broude L., Nemanov L., Gritsenko I., et al. Association of the serotonin transporter gene with smoking behavior. Am J Psychiatry 2005, 162(5):924-930.
54. Kuepper Y., Wielpuetz C., Alexander N., Mueller E., Grant P., Hennig J. 5-HTTLPR S-allele: a genetic plasticity factor regarding the effects of life events on personality?. Genes Brain Behav 2012, 11(6):643-650.
55. Lang P.J., McTeague L.M. The anxiety disorder spectrum: fear imagery, physiological reactivity, and differential diagnosis. Anxiety Stress Coping 2009, 22(1):5-25.
56. Le Melledo J.M., Merani S., Koszycki D., Bellavance F., Palmour R., Gutkowska J., et al. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases. Neuropsychopharmacology 1999, 20(1):81-91.
57. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274(5292):1527-1531.
58. Lesch K.P., Gutknecht L. Pharmacogenetics of the serotonin transporter. Progress in Neuro-psychopharmacology & Biological Psychiatry 2005, 29(6):1062-1073.
59. Lombardi F., Stein P.K. Origin of heart rate variability and turbulence: an appraisal of autonomic modulation of cardiovascular function. Front Physiol 2011, 2:95.
60. Long H., Liu B., Hou B., Wang C., Li J., Qin W., et al. The long rather than the short allele of 5-HTTLPR predisposes Han Chinese to anxiety and reduced connectivity between prefrontal cortex and amygdala. Neurosci Bull 2013, 29(1):4-15.
61. Lovallo W.R., Farag N.H., Sorocco K.H., Cohoon A.J., Vincent A.S. Lifetime adversity leads to blunted stress axis reactivity: studies from the Oklahoma Family Health Patterns Project. Biol Psychiatry 2012, 71(4):344-349.
62. Maron E., Tasa G., Toru I., Lang A., Vasar V., Shlik J. Association between serotonin-related genetic polymorphisms and CCK-4-induced panic attacks with or without 5-hydroxytryptophan pretreatment in healthy volunteers. World J Biol Psychiatry 2004, 5(3):149-154.
63. McCaffery J.M., Bleil M., Pogue-Geile M.F., Ferrell R.E., Manuck S.B. Allelic variation in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) and cardiovascular reactivity in young adult male and female twins of European-American descent. Psychosom Med 2003, 65(5):721-728.
64. McTeague L.M., Lang P.J., Laplante M.C., Cuthbert B.N., Shumen J.R., Bradley M.M. Aversive imagery in posttraumatic stress disorder: trauma recurrence, comorbidity, and physiological reactivity. Biol Psychiatry 2010, 67(4):346-356.
65. Meyer M., Stiedl O. Self-affine fractal variability of human heartbeat interval dynamics in health and disease. Eur J Appl Physiol 2003, 90(3-4):305-316.
66. Miller R., Wankerl M., Stalder T., Kirschbaum C., Alexander N. The serotonin transporter gene-linked polymorphic region (5-HTTLPR) and cortisol stress reactivity: a meta-analysis. Mol Psychiatry 2013, 18(9):1018-1024.
67. Mitro P., Mudrakova K., Mickova H., Dudas J., Kirsch P., Valocik G. Hemodynamic parameters and heart rate variability during a tilt test in relation to gene polymorphism of Renin-angiotensin and serotonin system. Pace-Pacing and Clinical Electrophysiology 2008, 31(12):1571-1580.
68. Mueller A., Strahler J., Armbruster D., Lesch K.P., Brocke B., Kirschbaum C. Genetic contributions to acute autonomic stress responsiveness in children. Int J Psychophysiol 2012, 83(3):302-308.
69. Mueller E.M., Stemmler G., Hennig J., Wacker J. 5-HTTLPR and anxiety modulate brain-heart covariation. Psychophysiology 2013, 50(5):441-453.
70. Murakami H., Matsunaga M., Ohira H. Association of serotonin transporter gene polymorphism and emotion regulation. Neuroreport 2009, 20(4):414-418.
71. Neumeister A., Hu X.Z., Luckenbaugh D.A., Schwarz M., Nugent A.C., Bonne O., et al. Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls. Arch Gen Psychiatry 2006, 63(9):978-986.
72. Ni W., Watts S.W. 5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT). Clin Exp Pharmacol Physiol 2006, 33(7):575-583.
73. Nielsen T., Paquette T., Solomonova E., Lara-Carrasco J., Colombo R., Lanfranchi P. Changes in cardiac variability after REM sleep deprivation in recurrent nightmares. Sleep 2010, 33(1):113-122.
74. Ogren S.O., Eriksson T.M., Elvander-Tottie E., D'Addario C., Ekstrom J.C., Svenningsson P., et al. The role of 5-HT(1A) receptors in learning and memory. Behav Brain Res 2008, 195(1):54-77.
75. Osher Y., Hamer D., Benjamin J. Association and linkage of anxiety-related traits with a functional polymorphism of the serotonin transporter gene regulatory region in Israeli sibling pairs. Mol Psychiatry 2000, 5(2):216-219.
76. Otte C., McCaffery J., Ali S., Whooley M.A. Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry 2007, 164(9):1379-1384.
77. Peng C.K., Buldyrev S.V., Hausdorff J.M., Havlin S., Mietus J.E., Simons M., et al. Non-equilibrium dynamics as an indispensable characteristic of a healthy biological system. Integr Physiol Behav Sci 1994, 29(3):283-293.
78. Phillips A.C. Blunted cardiovascular reactivity relates to depression, obesity, and self-reported health. Biol Psychol 2011, 86(2):106-113.
79. Phillips A.C., Der G., Hunt K., Carroll D. Haemodynamic reactions to acute psychological stress and smoking status in a large community sample. Int J Psychophysiol 2009, 73(3):273-278.
80. Phillips A.C., Hughes B.M. Introductory paper: cardiovascular reactivity at a crossroads: where are we now?. Biol Psychol 2011, 86(2):95-97.
81. Pinheiro R.T., Coelho F.M., Silva R.A., Pinheiro K.A., Oses J.P., Quevedo Lde A., et al. Association of a serotonin transporter gene polymorphism (5-HTTLPR) and stressful life events with postpartum depressive symptoms: a population-based study. JPsychosom Obstet Gynaecol 2013, 34(1):29-33.
82. Pomeranz B., Macaulay R.J., Caudill M.A., Kutz I., Adam D., Gordon D., et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985, 248(1 Pt 2):H151-H153.
83. Ramage A.G. Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Research Bulletin 2001, 56(5):425-439.
84. Reinelt E., Stopsack M., Aldinger M., John U., Grabe H.J., Barnow S. Testing the diathesis-stress model: 5-HTTLPR, childhood emotional maltreatment, and vulnerability to social anxiety disorder. Am J Med Genet B Neuropsychiatr Genet 2013, 162B(3):253-261.
85. Reyes del Paso G.A., Langewitz W., Mulder L.J., van Roon A., Duschek S. The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies. Psychophysiology 2013, 50(5):477-487.
86. Salomon K., Clift A., Karlsdottir M., Rottenberg J. Major depressive disorder is associated with attenuated cardiovascular reactivity and impaired recovery among those free of cardiovascular disease. Health Psychol 2009, 28(2):157-165.
87. Schwerdtfeger A., Rosenkaimer A.K. Depressive symptoms and attenuated physiological reactivity to laboratory stressors. Biol Psychol 2011, 87(3):430-438.
88. Shinozaki G., Romanowicz M., Passov V., Rundell J., Mrazek D., Kung S. State dependent gene-environment interaction: serotonin transporter gene-child abuse interaction associated with suicide attempt history among depressed psychiatric inpatients. JAffect Disord 2013, 147(1-3):373-378.
89. Sookoian S., Gemma C., Garcia S.I., Gianotti T.F., Dieuzeide G., Roussos A., et al. Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) 2007, 15(2):271-276.
90. Stauss H.M., Persson P.B. Cardiovascular variability and the autonomic nervous system. JHypertens 2006, 24(9):1902-1905.
91. Stiedl O., Youn J., Jansen R.F. Cardiovascular conditioning: neural substrates. Encyclopedia of behavioral neuroscience 2010, Vol. 1:226-235. Elsevier, Amsterdam.
92. Thayer J.F., Ahs F., Fredrikson M., Sollers J.J., Wager T.D. Ameta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev 2012, 36(2):747-756.
93. Thayer J.F., Lane R.D. Amodel of neurovisceral integration in emotion regulation and dysregulation. JAffect Disord 2000, 61(3):201-216.
94. Thayer J.F., Lane R.D. Claude Bernard and the heart-brain connection: further elaboration of a model of neurovisceral integration. Neurosci Biobehav Rev 2009, 33(2):81-88.
95. Thayer J.F., Sternberg E. Beyond heart rate variability: vagal regulation of allostatic systems. Ann N Y Acad Sci 2006, 1088:361-372.
96. Verhoeven K.J.F., Simonsen K.L., McIntyre L.M. Implementing false discovery rate control: increasing your power. Oikos 2005, 108(3):643-647.
97. Wankerl M., Wust S., Otte C. Current developments and controversies: does the serotonin transporter gene-linked polymorphic region (5-HTTLPR) modulate the association between stress and depression?. Curr Opin Psychiatry 2010, 23(6):582-587.
98. Way B.M., Taylor S.E. Apolymorphism in the serotonin transporter gene moderates cardiovascular reactivity to psychosocial stress. Psychosom Med 2011, 73(4):310-317.
99. Weidner G., Kohlmann C.W., Horsten M., Wamala S.P., Schenck-Gustafsson K., Hogbom M., et al. Cardiovascular reactivity to mental stress in the Stockholm female coronary risk study. Psychosom Med 2001, 63(6):917-924.
100. Wiedemann K., Jahn H., Yassouridis A., Kellner M. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings. Arch Gen Psychiatry 2001, 58(4):371-377.
101. Williams R.B., Marchuk D.A., Siegler I.C., Barefoot J.C., Helms M.J., Brummett B.H., et al. Childhood socioeconomic status and serotonin transporter gene polymorphism enhance cardiovascular reactivity to mental stress. Psychosom Med 2008, 70(1):32-39.
102. Wu T., Snieder H., de Geus E. Genetic influences on cardiovascular stress reactivity. Neurosci Biobehav Rev 2010, 35(1):58-68.
103. Xie P., Kranzler H.R., Poling J., Stein M.B., Anton R.F., Brady K., et al. Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry 2009, 66(11):1201-1209.
104. Yang H., Durocher J.J., Larson R.A., Dellavalla J.P., Carter J.R. Total sleep deprivation alters cardiovascular reactivity to acute stressors in humans. JAppl Physiol 2012, 113(6):903-908.
105. York K.M., Hassan M., Li Q., Li H., Fillingim R.B., Sheps D.S. Coronary artery disease and depression: patients with more depressive symptoms have lower cardiovascular reactivity during laboratory-induced mental stress. Psychosom Med 2007, 69(6):521-528.
106. Youn J., Hager T., Misane I., Pieneman A.W., Jansen R.F., Ogren S.O., et al. Central 5-HT receptor-mediated modulation of heart rate dynamics and its adjustment by conditioned and unconditioned fear in mice. Br J Pharmacol 2013, 170(4):859-870.
107. Zhang H., Xu M., Xia J., Qin R.Y. Association between serotonin transporter (SERT) gene polymorphism and idiopathic pulmonary arterial hypertension: a meta-analysis and review of the literature. Metabolism 2013, 62(12):1867-1875.
108. Zwanzger P., Zavorotnyy M., Gencheva E., Diemer J., Kugel H., Heindel W., et al. Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide-A 3T-MRS study in healthy subjects. Neuropsychopharmacology 2013, 38(9):1648-1654.